Tested Applications
| Positive WB detected in | HaCaT cells, A431 cells, human saliva, rat skin tissue, mouse skin tissue |
| Positive IHC detected in | human tonsillitis tissue, human cervical cancer tissue, human lung cancer tissue, human oesophagus cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | human cervical cancer tissue |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunohistochemistry (IHC) | IHC : 1:5000-1:20000 |
| Immunofluorescence (IF)-P | IF-P : 1:200-1:800 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:400-1:1600 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
68295-1-Ig targets Cytokeratin 5/6 in WB, IHC, IF/ICC, IF-P, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, monkey |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11288 Product name: Recombinant human KRT6B protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 214-564 aa of BC034535 Sequence: FEQYINNLRRQLDNIVGERGRLDSELRNMQDLVEDLKNKYEDEINKRTAAENEFVTLKKDVDAAYMNKVELQAKADTLTDEINFLRALYDAELSQMQTHISDTSVVLSMDNNRNLDLDSIIAEVKAQYEEIAQRSRAEAESWYQTKYEELQITAGRHGDDLRNTKQEIAEINRMIQRLRSEIDHVKKQCANLQAAIADAEQRGEMALKDAKNKLEGLEDALQKAKQDLARLLKEYQELMNVKLALDVEIATYRKLLEGEECRLNGEGVGQVNISVVQSTVSSGYGGASGVGSGLGLGGGSSYSYGSGLGVGGGFSSSSGRATGGGLSSVGGGSSTIKYTTTSSSSRKSYKH Predict reactive species |
| Full Name | keratin 6B |
| Calculated Molecular Weight | 564 aa, 60 kDa |
| Observed Molecular Weight | 60 kDa |
| GenBank Accession Number | BC034535 |
| Gene Symbol | Cytokeratin 6B |
| Gene ID (NCBI) | 3854 |
| RRID | AB_2935375 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | P04259 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9-K23, and the hair keratins Ha1-Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1-K8, and the hair keratins, Hb1-Hb6. This antibody can react with Cytokeratin 5 and Cytokeratin 6.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Cytokeratin 5/6 antibody 68295-1-Ig | Download protocol |
| IHC protocol for Cytokeratin 5/6 antibody 68295-1-Ig | Download protocol |
| WB protocol for Cytokeratin 5/6 antibody 68295-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
68295-1-Ig Cytokeratin 5/6 Monoclonal Antibody has a total of 7 citations per the record.
Journals: Cancer Research, Journal of Controlled Release, Breast Cancer Research, The American Journal of Pathology, STAR Protocols, Journal of Comparative Pathology, and Advanced Science.
Research fields: Oncology — head and neck squamous cell carcinoma and ferroptosis, oral squamous cell carcinoma and tumor microenvironment (Salmonella therapy), breast cancer brain metastasis, endometrial carcinoma metaplasia, lung tumoroid protocols, veterinary pathology (pleomorphic adenoma in rhesus monkey), and DCIS/IDC multi-omics.
Applications used in citations: IHC and IF (human and monkey samples).
| Species | Application | Title |
|---|---|---|
Cancer Res TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma | ||
J Control Release Genetically engineered Salmonella, SGN1, as a tumor microenvironment-targeting modality capable of methionine reduction for oral squamous cell carcinoma. | ||
Breast Cancer Res CD19(+)Ki67(+)B cells regulated by NAMPT as key modulators in triple-negative breast cancer with brain metastasis. | ||
Am J Pathol Molecular Switching from Morule to Squamous Metaplasia via p40 and the EBP50/S100A4/Myosin 9 Axis in Endometrial Carcinoma. | ||
STAR Protoc Protocol for the establishment and characterization of lung tumoroids from surgical resection without the use of Matrigel | ||
J Comp Pathol Myoepithelial-rich pleomorphic adenoma of the soft palate in a rhesus monkey (Macaca mulatta) |























